Biomedical Engineering Technology Accelerator (BioMedX)
Pre-Proposal Applications for the 2024 - 2025 cycle are now closed.
The Biomedical Engineering Technology Accelerator aims to catalyze the advancement of biomedical technologies by providing funding, education, resources and mentorship to interdisciplinary teams of clinicians, engineers, scientists and students working to develop solutions to clinical unmet needs, with the ultimate goal of bringing innovative research out of the lab to benefit society. Project support is expected to serve as a bridge to commercial investment, with awards granted to perform specific tasks needed to validate a commercial hypothesis (vs. a scientific hypothesis). Award recipients are encouraged to submit their funded research outcomes for publication in academic journals, as usual.
Timeline
Cumulative Success Metrics
- 11 cycles administered
- 222 applications received
- 157 teams admitted to/went through accelerator
- 72 awards given
- Over $5.6M in funding awarded by BiomedX to teams
- $86M in follow-on funding awarded to teams by external sources
2020 Founder's Spotlights
Student Venture Associate Kush Mody had a chance to virtually sit down with cohort member Dr. Kacey Ronaldson of Link Biosystems. Based on research from the lab of Dr. Gordana Vunjak-Novacovic, Link Biosystems is creating a systemic human pre-clinical model for cancer drug development.